TITLE

Developing new drugs is now taking much longer

PUB. DATE
October 2009
SOURCE
Slovak Spectator;10/12/2009, Vol. 15 Issue 39, p11
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
45454673

 

Related Articles

  • Winning the drugs war. Ridley, Robert; Toure, Yeya // Nature;8/19/2004, Vol. 430 Issue 7002, p942 

    The outlook for new antimalarials is now better than it has been for decades, it is because of public-private partnerships and increased funds for countries to buy drugs. The brighter outlook for new drugs is in large part due to the nonprofit organization Medicines for Malaria Venture,...

  • The Secret Marketer.  // Marketing Week (01419285);3/1/2012, Vol. 35 Issue 9, p14 

    The author comments on whether marketing agencies and suppliers getting soft in their approaches for new business. He says that it may be due to email and social media taking the cost and the graft out of it. According to him, business development people no longer have to care so much about...

  • Antimicrobials & cholera: are we stranded? Ghosh, Amit; Ramamurthy, T. // Indian Journal of Medical Research;Feb2011, Vol. 133 Issue 2, p225 

    Antimicrobial resistance poses a major threat in the treatment of infectious diseases. Though significant progress in the management of diarrhoeal diseases has been achieved by improved hygiene, development of new antimicrobials and vaccines, the burden remains the same, especially in children...

  • The FDA's deadly approval process. Kazman, S. // Consumers' Research Magazine;Apr91, Vol. 74 Issue 4, p31 

    Opinion. Argues against the length of time it takes for the Food and Drug Administration to approve a new drug. Thalidomide; Fewer new drugs; Regulator's priorities; Death by too much safety; Better access to drugs.

  • Financial sector visit to Showcase.  // Management Services;Dec1980, Vol. 24 Issue 12, p37 

    Showcase is a series of one day seminars designed to put over International Business Machines' Corp. (IBM) concept of the office of the future. Aimed at the non computer professional, IBM kindly agreed to take a block booking from the Financial Sector Group, resulting in 28 members turning up,...

  • Independent Nurse: Opinion - Emma Bower - More opportunities than ever for nurses. Bower, Emma // GP: General Practitioner;11/25/2005, p103 

    The article discusses various issues related to drug prescription privileges to nurses. Nurses will no longer have to worry about whether they are allowed to prescribe a particular drug for a specific condition, stand around in corridors waiting for GPs to sign scrips or endlessly update...

  • AIDS drug success.  // New Scientist;5/2/92, Vol. 134 Issue 1819, p11 

    Reports that men with HIV who start taking zidovudine (AZT) before they develop symptoms may live longer than those who wait. Finding based on a study of 2500 men with HIV; Study published in the `New England Journal of Medicine.' Results with a combination of AZT and a drug to prevent...

  • A Mix-Up in Priorities. Margolis, Mac // Newsweek (Atlantic Edition);4/5/2004 (Atlantic Edition), Vol. 143 Issue 14, p49 

    Reports that public health researchers are warning that the U.S. government is focusing too much on combating relatively rare illnesses like SARS and anthrax, and too little on common diseases across the world, such as tuberculosis, AIDS and malaria. Details of charges made by New Jersey Medical...

  • A Mix-Up in Priorities. Margolis, Mac // Newsweek (Pacific Edition);4/5/2004 (Pacific Edition), Vol. 143 Issue 14, p41 

    Reports that public health researchers are warning that the U.S. government is focusing too much on combating relatively rare illnesses like SARS and anthrax, and too little on common diseases across the world, such as tuberculosis, AIDS and malaria. Details of charges made by New Jersey Medical...

  • Ophthalmic Drug Delivery System: Challenges and Approaches. Patel, P. B.; Shastri, D. H.; Shelat, P. K.; Shukla, A. K. // Systematic Reviews in Pharmacy;Jul2010, Vol. 1 Issue 2, p113 

    Promising management of eye ailments take off effective concentration of drug at the eye for sufficient period of time. Ocular drug delivery is hampered by the barriers protecting the eye. The bioavailability of the active drug substance is often the major hurdle to overcome. Conventional ocular...

Share

Read the Article

Other Topics